Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsHematopoietic Stem CellsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisMice, Inbred C57BLKidney TransplantationCell DifferentiationRadiation ChimeraRecurrenceCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationTime FactorsImmunosuppressive AgentsRemission InductionTreatment OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsGraft RejectionBone RemodelingStem Cell TransplantationHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone Marrow NeoplasmsStem CellsTransplantation ImmunologyGraft vs Host ReactionImmunosuppressionLymphocyte DepletionColony-Forming Units AssayAcute DiseaseLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationT-LymphocytesChimeraSevere Combined ImmunodeficiencyCells, CulturedMyelodysplastic SyndromesHLA AntigensSurvival AnalysisRetrospective StudiesLung TransplantationLymphocyte TransfusionCyclosporineBone DensityActuarial AnalysisHematologic DiseasesSpleenNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryCarmustineOrgan TransplantationBone ResorptionProtein PrecursorsPancytopeniaMice, Inbred BALB CGraft vs Tumor EffectLeukocyte CountFollow-Up StudiesGraft vs Leukemia EffectCytarabineGranulocyte Colony-Stimulating FactorSurvival RateCytomegalovirus InfectionsCell LineageMice, KnockoutAntigens, CD34MelphalanDisease-Free SurvivalLymphomaGranulocytesCell TransplantationEtoposideMultiple MyelomaThymus GlandMice, Transgenic